Aura Biosciences, Inc. SEC filings AURA
Aura Biosciences, Inc. has 381 filings in SEC EDGAR's recent list, going back to Sep 21, 2010. Its latest annual report, Form ARS, was filed on Apr 20, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 11, 2026 (results of operations, exit or restructuring costs, officer or director change, other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Aug 20, 2026 | — |
| CORRESP | Letter to the SEC | Aug 18, 2026 | — |
| UPLOAD | Letter from the SEC | Aug 17, 2026 | — |
| EFFECT | Filing | Apr 5, 2024 | — |
| CORRESP | Letter to the SEC | Apr 3, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2024 | — |
| EFFECT | Filing | Nov 7, 2022 | — |
| CORRESP | Letter to the SEC | Nov 3, 2022 | — |
| UPLOAD | Letter from the SEC | Nov 3, 2022 | — |
| EFFECT | Filing | Oct 28, 2021 | — |
| SEC STAFF LETTER | Filing | Oct 28, 2021 | — |
| CERT | Filing | Oct 28, 2021 | — |
| 8-A12B | Filing | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 26, 2021 | — |
| CORRESP | Letter to the SEC | Oct 25, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 13, 2021 | — |
| CORRESP | Letter to the SEC | Oct 8, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 27, 2021 | — |
| SEC STAFF LETTER | Filing | Sep 21, 2021 | — |
| DRS/A | Filing | Sep 20, 2021 | — |
| DRSLTR | Filing | Sep 17, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 10, 2021 | — |
| DRS | Filing | Aug 10, 2021 | — |
| D | Filing | Apr 6, 2021 | — |
| D | Filing | Jul 9, 2020 | — |
| D | Filing | Apr 12, 2019 | — |
| D/A | Filing | Dec 13, 2018 | — |
| D | Filing | Jan 3, 2018 | — |
| D/A | Filing | Nov 2, 2017 | — |
| D | Filing | Sep 30, 2016 | — |
| D | Filing | Mar 5, 2015 | — |
| D | Filing | Aug 14, 2014 | — |
| D | Filing | Jan 8, 2014 | — |
| D | Filing | Dec 26, 2012 | — |
| D | Filing | Aug 26, 2011 | — |
| D | Filing | Sep 21, 2010 | — |
Showing 37 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AURA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Boston, MA
- SEC filer status
- Non-accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1501796
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.